Fournier gangrene epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Fournier gangrene}} {{SCC}}; {{AE}} {{YK}}; {{JH}} ==Overview== ==References== {{Reflist|2}}") |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Epidemiology and Demographics== | |||
===Incidence=== | |||
[[Incidence]] of Fournier gangrene in the United states:<ref name="pmid27172977">{{cite journal| author=Sorensen MD, Krieger JN| title=Fournier's Gangrene: Epidemiology and Outcomes in the General US Population. | journal=Urol Int | year= 2016 | volume= 97 | issue= 3 | pages= 249-259 | pmid=27172977 | doi=10.1159/000445695 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27172977 }} </ref> | |||
*The overall [[incidence]] of Fournier gangrene annually is 1.6 cases per 100,000 males. The [[incidence]] peaked and remained steady after age 50 at 3.3 cases per 100,000 males. | |||
*The [[incidence]] of Fournier gangrene increased 0.2 per 100,000 males for each 1% increase in the regional prevalence of [[diabetes]]. | |||
*The [[incidence rate]] was highest in the southern U.S. and lowest in the western and mid-western U.S. | |||
<gallery> | |||
Image:Epidemiology.jpg|1000px|Distribution of annual cases per hospital.<ref name="pmid27172977">{{cite journal| author=Sorensen MD, Krieger JN| title=Fournier's Gangrene: Epidemiology and Outcomes in the General US Population. | journal=Urol Int | year= 2016 | volume= 97 | issue= 3 | pages= 249-259 | pmid=27172977 | doi=10.1159/000445695 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27172977 }} </ref> | |||
</gallery> | |||
===Age=== | |||
Fournier gangrene affects individuals of all ages but more commonly affects individuals older than 50 years of age.<ref name="pmid23251819">{{cite journal| author=Mallikarjuna MN, Vijayakumar A, Patil VS, Shivswamy BS| title=Fournier's Gangrene: Current Practices. | journal=ISRN Surg | year= 2012 | volume= 2012 | issue= | pages= 942437 | pmid=23251819 | doi=10.5402/2012/942437 | pmc=3518952 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23251819 }} </ref><ref name="pmid23578806">{{cite journal| author=Shyam DC, Rapsang AG| title=Fournier's gangrene. | journal=Surgeon | year= 2013 | volume= 11 | issue= 4 | pages= 222-32 | pmid=23578806 | doi=10.1016/j.surge.2013.02.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23578806 }} </ref> | |||
===Gender=== | |||
Men are more commonly affected with Fournier gangrene than women, with a male:female ratio of 10:1.<ref name="pmid26445600">{{cite journal| author=Chennamsetty A, Khourdaji I, Burks F, Killinger KA| title=Contemporary diagnosis and management of Fournier's gangrene. | journal=Ther Adv Urol | year= 2015 | volume= 7 | issue= 4 | pages= 203-15 | pmid=26445600 | doi=10.1177/1756287215584740 | pmc=4580094 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26445600 }} </ref><ref name="pmid23578806">{{cite journal| author=Shyam DC, Rapsang AG| title=Fournier's gangrene. | journal=Surgeon | year= 2013 | volume= 11 | issue= 4 | pages= 222-32 | pmid=23578806 | doi=10.1016/j.surge.2013.02.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23578806 }} </ref> | |||
===Mortality=== | |||
*Mortality rate decreases with early aggressive treatment. | |||
*The mortality rate of Fournier gangrene is between 20% to 80%. Higher mortality rates are found in [[diabetes|daibetics]], alcoholics and those with colorectal sources of [[infection]].<ref name="pmid20062653">{{cite journal| author=Moslemi MK, Sadighi Gilani MA, Moslemi AA, Arabshahi A| title=Fournier gangrene presenting in a patient with undiagnosed rectal adenocarcinoma: a case report. | journal=Cases J | year= 2009 | volume= 2 | issue= | pages= 9136 | pmid=20062653 | doi=10.1186/1757-1626-2-9136 | pmc=2803933 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20062653 }} </ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 19:54, 6 September 2017
|
Fournier gangrene Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fournier gangrene epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Fournier gangrene epidemiology and demographics |
|
Risk calculators and risk factors for Fournier gangrene epidemiology and demographics |
Steven C. Campbell, M.D., Ph.D.; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[1]; Jesus Rosario Hernandez, M.D. [2]
Overview
Epidemiology and Demographics
Incidence
Incidence of Fournier gangrene in the United states:[1]
- The overall incidence of Fournier gangrene annually is 1.6 cases per 100,000 males. The incidence peaked and remained steady after age 50 at 3.3 cases per 100,000 males.
- The incidence of Fournier gangrene increased 0.2 per 100,000 males for each 1% increase in the regional prevalence of diabetes.
- The incidence rate was highest in the southern U.S. and lowest in the western and mid-western U.S.
-
![Distribution of annual cases per hospital.[1]](/images/4/45/Epidemiology.jpg)
Distribution of annual cases per hospital.[1]
![Distribution of annual cases per hospital.[1]](/index.php/File:Epidemiology.jpg)
Age
Fournier gangrene affects individuals of all ages but more commonly affects individuals older than 50 years of age.[2][3]
Gender
Men are more commonly affected with Fournier gangrene than women, with a male:female ratio of 10:1.[4][3]
Mortality
- Mortality rate decreases with early aggressive treatment.
- The mortality rate of Fournier gangrene is between 20% to 80%. Higher mortality rates are found in daibetics, alcoholics and those with colorectal sources of infection.[5]
References
- ↑ 1.0 1.1 Sorensen MD, Krieger JN (2016). "Fournier's Gangrene: Epidemiology and Outcomes in the General US Population". Urol Int. 97 (3): 249–259. doi:10.1159/000445695. PMID 27172977.
- ↑ Mallikarjuna MN, Vijayakumar A, Patil VS, Shivswamy BS (2012). "Fournier's Gangrene: Current Practices". ISRN Surg. 2012: 942437. doi:10.5402/2012/942437. PMC 3518952. PMID 23251819.
- ↑ 3.0 3.1 Shyam DC, Rapsang AG (2013). "Fournier's gangrene". Surgeon. 11 (4): 222–32. doi:10.1016/j.surge.2013.02.001. PMID 23578806.
- ↑ Chennamsetty A, Khourdaji I, Burks F, Killinger KA (2015). "Contemporary diagnosis and management of Fournier's gangrene". Ther Adv Urol. 7 (4): 203–15. doi:10.1177/1756287215584740. PMC 4580094. PMID 26445600.
- ↑ Moslemi MK, Sadighi Gilani MA, Moslemi AA, Arabshahi A (2009). "Fournier gangrene presenting in a patient with undiagnosed rectal adenocarcinoma: a case report". Cases J. 2: 9136. doi:10.1186/1757-1626-2-9136. PMC 2803933. PMID 20062653.